impacts the results and discussion sections, which are written in a more general way than I think the authors intend. 4. Line 126, the authors suggest that data was collected via a handwritten response. The reason for this is never elaborated or referred to again in the manuscript. Was it decided at the outset that written responses would be accepted, or did this materialize during the data collection period? I think in both scenarios it needs to be clear to the reader why? 5. In line 126/127 and again in line139 the authors state the aim to be exploring the reasons practices used CRP POCT often or less frequently, but it is not clear in the manuscript how this was discerned. What was considered high/low use? How was this information obtained e.g. from practice records, audits etc. 6. Who are the target population? In several places "a range of practice staff" is used, which is quite vague. Can you be a little more explicit, particularly early on in the methods. Really spell out who you are approaching, and who you are not (including justification) 7. In line 161, the authors state "after reflection the COM-B framework was considered the most appropriate." This reads as a little off the cuff. Was this framework identified prior to data collection, or as data was starting to be collected? 8. Can the authors elaborate on the reasoning for using both interviews AND focus groups, and which participants participated in each? What was the intention of this approach? Did the authors first have one-on-one interviews with practice staff and then select some of to participate in focus groups? Why? Did you separate out focus groups by practice roles, or have a mixture of staff in each, and why? I appreciate the justification is alluded to in the discussion, but I think being explicit in the methods would improve reproducibility of the study RESULTS 9. For data analysis, it is unclear whether the authors coded/develop themes with the COM-B framework in mind? Was an inductive or deductive (or mixed) approach used? I am unclear why "the findings were implemented into the COM-B framework and discussed" means? If the themes were developed inductively, as is suggested, how were they reconciled with the COM-B framework? or was there an extra stage in the analysis? 10. Line 220 -224: multiple groups e.g. A -E, representing high/low users of CRP POCT and antibiotic prescribing practices are introduced into the results section. I understood the authors to only have targeted practices within high prescribing CCGs, but the results section includes a group (F) of low prescribers? This comes out of left-field. Introducing any terminology/groups early in the methods and keeping terminology consistent throughout the manuscript would improve readability. 11. There is a lot of data presented in the results section that doesn't quite flow and is not cohesive. I think this would be helped by improving clarity of the objectives of this study. I am not clear where the data in Table 1 has come from. I am assuming it has been derived from the interviews/focus groups? If so, I think this data might be better narrowed down towards the end of the qualitative narrative. 12. The narrative is written well. I think being more explicit about the views of those held within the high, medium, low uptake (intervention), or control groups within each domain would strengthen the results, and would better prepare the reader for the content in Table 1 . Also, new phrases introduced "intervention" and "control" -introduce in the methods. 13. Possibly a bit picky, but be clear to state POCT. CRP is often used as a lab test, and there are times when it is not clear whether you are referring to CRP POCT or use of the marker more generally e.g. Table 1 . DISCUSSION 14. In the strengths and limitations I think the assumption is that "high" prescribing practices may be utilizing antibiotics more inappropriately than lower prescribing practices. Whilst this may be true, I don't think a straight line can be drawn between prescribing rates and appropriateness of those prescribing behaviors. The observed high prescribing rates may be confounded by the demographics practices serve, for example. Do these practices have higher proportions of elderly patients with comorbidities (and whom may be at greater risk of developing pneumonia than younger adults). The authors might consider acknowledging some of the limitations of just approaching high prescribing practices? 15. The first two paragraphs in the principal findings are written very generally. IF the objective of the study was to improve understanding of barriers and facilitators of CRP POCT among those practices with different utilization patterns, state key findings regarding this in this early section.
REVIEWER
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GENERAL COMMENTS
First, while I have done research on point of care testing and respiratory infections, I am not an expert on qualitative research.
General comments
The results are somewhat UK-centric, since other countries have different policies regarding reimbursement for point of care tests. Also, CRP is not available as a POCT in some countries (i.e. USA). That is not a major criticism, but should be acknowledged.
Strengths of the study include a random selection of practices for generalizability, and what seem to be solid qualitative methods for gathering a rich set of data.
Abstract: Should define CRP and POCT before using acronyms, even in abstract.
Introduction. The estimate of 23% of antibiotics prescribed being unnecessary is low for respiratory infections, and again is countryspecific. Countries with higher prescribing rates have more inappropriate use, and vice versa. Specify that 23% applies to UK, and is for any antibiotic use (including UTI, skin infection) not just LRTI.
Methods: Research design: "...some practices completed" and "...some practices declined"
Methods: study setting: What is the point of the "further randomly selected practice"?
Methods: To what extent were participating practices trained in use of CRP? (I see now that is mentioned in results, but seems like it belongs in methods
Results
The results are well organized. I'm not sure the COM-B framework is the best fit here, but seems adequate. Results are quite lengthy, but for online only publication that is not as much of an issue.
Discussion
As noted above, limitation is that many of the comments, barriers, and challenges identified are somewhat unique to the UK health system and context.
Not sure who you mean when you say "Implications for commissioners". Commissioners of what?
Overall Discussion seems reasonable and does not exceed the bounds of the results. 
REVIEWER

GENERAL COMMENTS
I find the study well done. The topic is very important as CRP rapid testing has shown to safely reduce the number of antibiotics prescribed for lower respiratory tract infections, and we can assume that widespread utilisation of this test in mainly uncertain cases could be accompanied by a reduction of unnecessary antibiotic prescribing. However, the study is not original since other papers have addressed the facilitators and barriers about the uptake of the CRP rapid testing. In addition, two of these studies have already been recently published in the BMJ Open (Huddy JR et al. BMJ Open 2016;6:e009959 and Hardy V et al. BMJ Open 2017; 7:e012503) . You should make a stronger point in this paper about why your study is really necessary. I know that you used a specific method aligning the responses given by the staff to the Capability/Opportunity/Motivation-B framework, which is innovative, and you recruited general practice staff from mainly practices with high antibiotic consumption, but many of the topics that come up in your study have already been described earlier.
You should also explain the low recruitment rate achieved more in depth. You mention that 8 out of 20 practices refused to participate in this study despite the payment offered to the primary care professionals. Since one of the reasons for your study was to provide knowledge of the barriers related to widespread use of this point-of-care test in England, do you think that the topics raised in your study would have been different if all the practices had participated?
Linked to the previous comment, according to the literature GPs are enthusiastic about the use of rapid testing in general when they are first provided with these tests, but this enthusiasm wanes over time while using the rapid testing. Do you think that this could explain why some practices rejected the study?
Some concerns pointed out by GPs in other studies were not collected in your study. This has the potential to be an interesting paper examining the barriers and facilitators of CRP POCT adoption into routine primary care practice in the UK. The fact that it leverages experiences of CRP POCT among clinic staff during a trial rollout period offers a refreshing perspective of how CRP POCT is perceived by those utilizing it, and those yet to. However, I think this manuscript could be considerably improved by considering some of the following suggestions:
The authors state in line 116 that "no studies to date have been undertaken in routine primary care settings". There are a couple of studies that have been done that have explored the barriers and facilitators to use of CRP POCT in primary care practice in the UK, which the authors might consider acknowledging in the Introduction -Van Den Bruel (2015) C-reactive protein point-of-care testing in acutely ill children: a mixed methods study in primary care RESPONSE: Thank you for your comment -we have included additional studies into the introduction. This test group (children) is different to the adults tested in our trial, but it is certainly worth mentioning that parents, GPs and nurses provided their views on CRP POCT so it has been added to the manuscript introduction/discussion. METHODS 2. The authors state this research as a nested qualitative study, but the context presented is very vague. I understand this research to be a service evaluation undertaken as part of a programmatic trial period of CRP POCT in a region in the UK. Assuming this interpretation is correct, it would be helpful for the reader to know a little more about this trial rollout early on in the manuscript (either at the end of the Intro/beginning of methods), rather than dispersed throughout the manuscript. i.e. when did this rollout begin, when were practices approached relative to the commencement of the program, were all involved practices approached, why did the authors only target practices within a high prescribing NHS CCG (and how is high prescribing defined) etc. RESPONSE: Thank you for your suggestions and we agree. We have included more clear and thorough information about the trial in the methods section. We targeted practices within a high prescribing NHS CCG as it followed a trial which provided time relevant views of GP staff.
3. I am not 100% clear on what the aim of this study is. Is it to explore the attitudes etc. of clinic staff towards CRP POCT to get a better understanding of practice utilization patterns or to understand the barriers & facilitators of use more generally. This needs to be made more explicit and consistent throughout the manuscript as this impacts the results and discussion sections, which are written in a more general way than I think the authors intend. RESPONSE: The main aim was to explore the attitudes of general practice staff towards CRP POCT to understand the barriers and facilitators of using CRP POCT in general practice. The understanding of practice utilisation patterns will be discussed in the wider paper on the trial. The aim has been reworded substantially for clarity.
4. Line 126, the authors suggest that data was collected via a handwritten response. The reason for this is never elaborated or referred to again in the manuscript. Was it decided at the outset that written responses would be accepted, or did this materialize during the data collection period? I think in both scenarios it needs to be clear to the reader why? RESPONSE: Thank you for highlighting this. 1 clinician replied to the invitation saying they were happy to give written responses but not interview and we were happy to accept this. It is discussed in the data collection section.
5. In line 126/127 and again in line139 the authors state the aim to be exploring the reasons practices used CRP POCT often or less frequently, but it is not clear in the manuscript how this was discerned. What was considered high/low use? How was this information obtained e.g. from practice records, audits etc. RESPONSE: Thank you -we have re-worded this to facilitators and barriers.
6. Who are the target population? In several places "a range of practice staff" is used, which is quite vague. Can you be a little more explicit, particularly early on in the methods. Really spell out who you are approaching, and who you are not (including justification) RESPONSE: We agree -we have clarified this in the manuscript in the participants section.
7. In line 161, the authors state "after reflection the COM-B framework was considered the most appropriate." This reads as a little off the cuff. Was this framework identified prior to data collection, or as data was starting to be collected? RESPONSE: We have reworded this line as we used the COM-B framework to develop the interview questions as well so it was considered the most appropriate before data collection.
8. Can the authors elaborate on the reasoning for using both interviews AND focus groups, and which participants participated in each? What was the intention of this approach? Did the authors first have one-on-one interviews with practice staff and then select some of to participate in focus groups? Why? Did you separate out focus groups by practice roles, or have a mixture of staff in each, and why? I appreciate the justification is alluded to in the discussion, but I think being explicit in the methods would improve reproducibility of the study.
RESPONSE: Thank you for highlighting this. We have updated the section on data collection to answer your questions.
RESULTS
9. For data analysis, it is unclear whether the authors coded/develop themes with the COM-B framework in mind? Was an inductive or deductive (or mixed) approach used? I am unclear why "the findings were implemented into the COM-B framework and discussed" means? If the themes were developed inductively, as is suggested, how were they reconciled with the COM-B framework? or was there an extra stage in the analysis? RESPONSE: There was an extra stage in the analysis and we agree this is not currently clear so have updated this section to try to ensure clarity.
10. Line 220 -224: multiple groups e.g. A -E, representing high/low users of CRP POCT and antibiotic prescribing practices are introduced into the results section. I understood the authors to only have targeted practices within high prescribing CCGs, but the results section includes a group (F) of low prescribers? This comes out of left-field. Introducing any terminology/groups early in the methods and keeping terminology consistent throughout the manuscript would improve readability. RESPONSE: This is a reasonable suggestion. When we referred to "lower antibiotic prescribers" we were still referring to practices in a high prescribing CCG but just not the very highest of prescribers in that CCG. We have therefore updated our category to be: CONTROL -very high prescribing practices (previously higher prescribing practices) CONTROL -high prescribing practices (previously lower prescribing practices).
11. There is a lot of data presented in the results section that doesn't quite flow and is not cohesive. I think this would be helped by improving clarity of the objectives of this study. I am not clear where the data in Table 1 has come from. I am assuming it has been derived from the interviews/focus groups? If so, I think this data might be better narrowed down towards the end of the qualitative narrative. RESPONSE: We have moved the table to after the narrative and quotes to summarise the findings. We have also added some text to explain the table better.
12. The narrative is written well. I think being more explicit about the views of those held within the high, medium, low uptake (intervention), or control groups within each domain would strengthen the results, and would better prepare the reader for the content in Table 1 . Also, new phrases introduced "intervention" and "control" -introduce in the methods. RESPONSE: Thank you for your suggestion -we have updated and are mentioned in the METHODS participants section.
13. Possibly a bit picky, but be clear to state POCT. CRP is often used as a lab test, and there are times when it is not clear whether you are referring to CRP POCT or use of the marker more generally e.g. Table 1 . RESPONSE: Agree -thank you. DISCUSSION 14. In the strengths and limitations I think the assumption is that "high" prescribing practices may be utilizing antibiotics more inappropriately than lower prescribing practices. Whilst this may be true, I don't think a straight line can be drawn between prescribing rates and appropriateness of those prescribing behaviors. The observed high prescribing rates may be confounded by the demographics practices serve, for example. Do these practices have higher proportions of elderly patients with comorbidities (and whom may be at greater risk of developing pneumonia than younger adults). The authors might consider acknowledging some of the limitations of just approaching high prescribing practices? RESPONSE: Thank you for your comments. We have highlighted this in the discussion section as a limitation.
INTRODUCTION
The estimate of 23% of antibiotics prescribed being unnecessary is low for respiratory infections, and again is country-specific. Countries with higher prescribing rates have more inappropriate use, and vice versa. Specify that 23% applies to UK, and is for any antibiotic use (includingUTI, skin infection) not just LRTI. RESPONSE: Thank you for highlighting this. We have updated this statement to reflect it is for the UK and added some more figures for reference to RTIs.
METHODS
Research design: "...some practices completed" and "...some practices declined" RESPONSE: We have added this to the research design section. Study setting: What is the point of the "further randomly selected practice"? RESPONSE: We have added information to the study setting section to highlight that we required additional controls as we wanted to get a range of participants from a range of practices who had and hadn't used CRP POCT.
To what extent were participating practices trained in use of CRP? (I see now that is mentioned in results, but seems like it belongs in methods RESPONSE: Thank you -we have now also included this in the methods as well.
RESULTS
The results are well organized. I'm not sure the COM-B framework is the best fit here, but seems adequate. Results are quite lengthy, but for online only publication that is not as much of an issue. RESPONSE: Thank you.
DISCUSSION
As noted above, limitation is that many of the comments, barriers, and challenges identified are somewhat unique to the UK health system and context. I find the study well done. The topic is very important as CRP rapid testing has shown to safely reduce the number of antibiotics prescribed for lower respiratory tract infections, and we can assume that widespread utilisation of this test in mainly uncertain cases could be accompanied by a reduction of unnecessary antibiotic prescribing. However, the study is not original since other papers have addressed the facilitators and barriers about the uptake of the CRP rapid testing. In addition, two of these studies have already been recently published in the BMJ Open (Huddy JR et al. BMJ Open 2016; 6:e009959 and Hardy V et al. BMJ Open 2017; 7:e012503) . You should make a stronger point in this paper about why your study is really necessary. I know that you used a specific method aligning the responses given by the staff to the Capability/Opportunity/Motivation-B framework, which is innovative, and you recruited general practice staff from mainly practices with high antibiotic consumption, but many of the topics that come up in your study have already been described earlier.
RESPONSE: Thank you for your comments. We have reported in more depth on other studies and explained why our study is innovative qualitative research following routine general practice rather than research practices.
You should also explain the low recruitment rate achieved more in depth. You mention that 8 out of 20 practices refused to participate in this study despite the payment offered to the primary care professionals. Since one of the reasons for your study was to provide knowledge of the barriers related to widespread use of this point-of-care test in England, do you think that the topics raised in your study would have been different if all the practices had participated? RESPONSE: Thank you for your comments; we have added this into the discussion. We reached data saturation from our sample of 26 participants from 12 practices and so do not feel that the other 8 practices would raise other main themes.
Linked to the previous comment, according to the literature GPs are enthusiastic about the use of rapid testing in general when they are first provided with these tests, but this enthusiasm wanes over time while using the rapid testing. Do you think that this could explain why some practices rejected the study? RESPONSE: In this study this is the first time the practices had used CRP POCT so we do not feel this would be an explanation for why some practices rejected the study. 7 out of 8 intervention practices accepted interviews; it was mainly the practices that declined CRP or the controls that rejected the interview invitation.
Some concerns pointed out by GPs in other studies were not collected in your study. The overuse of this rapid testing, which might result in overmedicalisation of minor ailments and constitutes one of the fears of Scandinavian primary care staff and policy makers, has not been described in your study as one of the cons of the widespread use of CRP rapid testing. You know that the misuse of this point-of-care test in general practice is not marginal. For instance, in Hardy's paper some US primary care professionals mentioned that the overuse of these tests could result in an increase in the antibiotic prescribing rate. Could you explain why some topics mentioned in other similar papers have not been included in yours? RESPONSE: A very interesting point thank you. These topics were not major themes in the current study; they were mentioned by 1 individual but were not considered major themes across all staff. However, we had added this in the manuscript in comparison of existing literature for transparency.
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